LENALIDOMIDE
Generic: LENALIDOMIDE
EXELAN PHARMACEUTICALS INC.Manufacturer
ORALRoute
LENALIDOMIDEActive Substance
2022-09-06Original Approval
LENALIDOMIDE is FDA application ANDA210435, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
6,562 reports
2
DIARRHOEA
4,276 reports
3
PLASMA CELL MYELOMA
3,466 reports
4
FATIGUE
3,411 reports
5
PNEUMONIA
3,325 reports
6
DEATH
3,137 reports
7
NEUTROPENIA
2,705 reports
8
RASH
2,523 reports
9
PRODUCT DOSE OMISSION ISSUE
2,394 reports
10
DRUG INEFFECTIVE
2,098 reports